Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan for prevention of recurrent ulcers during long-term NSAID therapy
NCT01456260Phase 3Completed
- Sponsor
- Takeda
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vonoprazan in gastric ulcer, duodenal ulcer, sponsored by Takeda. Started Sep 2011; status: completed.
02
Drugs
vonoprazan
03
Conditions
gastric ulcerduodenal ulcer
Beyond the preview
Go deeper on NCT01456260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01456260.